HCM
BMRA icon

Hollencrest Capital Management’s Biomerica BMRA Stock Holding History

Hollencrest Capital Management’s Portfolio BMRA Stock Details BMRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$352 Sell
200
-625
-76% -$1.34K ﹤0.01% 1144
2026
Q1 		$1.75K Sell
825
-625
-43% -$1.43K ﹤0.01% 1037
2025
Q4 		$3.65K Hold
1,450
– – ﹤0.01% 950
2025
Q3 		$4.1K Hold
1,450
– – ﹤0.01% 918
2025
Q2 		$4.58K Hold
1,450
– – ﹤0.01% 880
2025
Q1 		$6.58K Hold
1,450
– – ﹤0.01% 839
2024
Q4 		$3.48K Hold
1,450
– – ﹤0.01% 936
2024
Q3 		$3.8K Hold
1,450
– – ﹤0.01% 893
2024
Q2 		$5.1K Sell
1,450
-154
-10% -$784 ﹤0.01% 837
2024
Q1 		$10.7K Buy
1,604
+573
+56% +$4.66K ﹤0.01% 706
2023
Q4 		$10.3K Buy
1,031
+706
+217% +$5.34K ﹤0.01% 720
2023
Q3 		$2.23K Hold
325
– – ﹤0.01% 906
2023
Q2 		$3.54K Sell
325
-6,035
-95% -$71.5K ﹤0.01% 900
2023
Q1 		$95.1K Buy
6,360
+110
+2% +$2.37K 0.01% 376
2022
Q4 		$168K Buy
+6,250
New +$180K 0.02% 274

Other funds holding BMRA

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
NA
NewEdge Advisors New Orleans, Louisiana $33.6B AUM 31.03% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
HI
Harbour Investments Madison, Wisconsin $7.43B AUM 24.49% 1-Year Est. Return
IA
IFG Advisory Atlanta, Georgia $2.85B AUM 26.07% 1-Year Est. Return

Hollencrest Capital Management's BMRA Position: Q2 2026 in Review

Hollencrest Capital Management reduced its Biomerica (BMRA) stake by 76% in Q2 2026, selling an estimated $1.34K and leaving 200 shares worth $352. The position accounts for ﹤0.01% of the portfolio, ranked #1144.

Hollencrest Capital Management first reported a position in BMRA in Q4 2022 and has held it in 15 quarters since. The position peaked at $168K in Q4 2022. 15 funds tracked by Wall St. Rank hold BMRA as of Q2 2026.

  • Hollencrest Capital Management held 200 shares of Biomerica worth $352 as of Q2 2026.
  • Hollencrest Capital Management sold 625 Biomerica shares in Q2 2026, an estimated $1.34K.
  • Biomerica made up ﹤0.01% of Hollencrest Capital Management's portfolio in Q2 2026, its #1144 holding.
  • Hollencrest Capital Management first reported a position in Biomerica in Q4 2022 and has held it in 15 quarters since.
  • Hollencrest Capital Management's Biomerica position peaked at $168K in Q4 2022.
  • 15 funds tracked by Wall St. Rank held Biomerica as of Q2 2026.

Based on Hollencrest Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.